A549 cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXD1
|
ENSG00000251493.2 | forkhead box D1 |
FOXO1
|
ENSG00000150907.6 | forkhead box O1 |
FOXO6
|
ENSG00000204060.4 | forkhead box O6 |
FOXG1
|
ENSG00000176165.7 | forkhead box G1 |
FOXP1
|
ENSG00000114861.14 | forkhead box P1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXD1 | hg19_v2_chr5_-_72744336_72744359 | 0.75 | 8.8e-02 | Click! |
FOXP1 | hg19_v2_chr3_-_71632894_71632909 | 0.74 | 9.2e-02 | Click! |
FOXO1 | hg19_v2_chr13_-_41240717_41240735 | -0.61 | 2.0e-01 | Click! |
FOXG1 | hg19_v2_chr14_+_29236269_29236287 | 0.58 | 2.3e-01 | Click! |
FOXO6 | hg19_v2_chr1_+_41827594_41827594 | 0.28 | 6.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_134832808 | 1.24 |
ENST00000275767.3
|
TMEM140
|
transmembrane protein 140 |
chr2_+_66918558 | 1.23 |
ENST00000435389.1
ENST00000428590.1 ENST00000412944.1 |
AC007392.3
|
AC007392.3 |
chr1_-_12679171 | 1.15 |
ENST00000606790.1
|
RP11-474O21.5
|
RP11-474O21.5 |
chr10_-_101841588 | 1.06 |
ENST00000370418.3
|
CPN1
|
carboxypeptidase N, polypeptide 1 |
chr6_-_32122106 | 1.04 |
ENST00000428778.1
|
PRRT1
|
proline-rich transmembrane protein 1 |
chr5_-_38557561 | 0.96 |
ENST00000511561.1
|
LIFR
|
leukemia inhibitory factor receptor alpha |
chr16_+_4666475 | 0.92 |
ENST00000591895.1
|
MGRN1
|
mahogunin ring finger 1, E3 ubiquitin protein ligase |
chr4_+_124571409 | 0.81 |
ENST00000514823.1
ENST00000511919.1 ENST00000508111.1 |
RP11-93L9.1
|
long intergenic non-protein coding RNA 1091 |
chr8_-_8318847 | 0.79 |
ENST00000521218.1
|
CTA-398F10.2
|
CTA-398F10.2 |
chr22_-_31688431 | 0.78 |
ENST00000402249.3
ENST00000443175.1 ENST00000215912.5 ENST00000441972.1 |
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1 |
chr4_+_183370146 | 0.75 |
ENST00000510504.1
|
TENM3
|
teneurin transmembrane protein 3 |
chr13_-_46716969 | 0.70 |
ENST00000435666.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr7_-_99698338 | 0.69 |
ENST00000354230.3
ENST00000425308.1 |
MCM7
|
minichromosome maintenance complex component 7 |
chr7_+_134551583 | 0.69 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
chr2_+_97481974 | 0.62 |
ENST00000377060.3
ENST00000305510.3 |
CNNM3
|
cyclin M3 |
chr19_-_47734448 | 0.62 |
ENST00000439096.2
|
BBC3
|
BCL2 binding component 3 |
chr17_+_72426891 | 0.60 |
ENST00000392627.1
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr16_-_30107491 | 0.58 |
ENST00000566134.1
ENST00000565110.1 ENST00000398841.1 ENST00000398838.4 |
YPEL3
|
yippee-like 3 (Drosophila) |
chr4_-_141075330 | 0.56 |
ENST00000509479.2
|
MAML3
|
mastermind-like 3 (Drosophila) |
chr14_-_69262789 | 0.56 |
ENST00000557022.1
|
ZFP36L1
|
ZFP36 ring finger protein-like 1 |
chr19_-_50380536 | 0.55 |
ENST00000391832.3
ENST00000391834.2 ENST00000344175.5 |
AKT1S1
|
AKT1 substrate 1 (proline-rich) |
chr3_-_46608010 | 0.55 |
ENST00000395905.3
|
LRRC2
|
leucine rich repeat containing 2 |
chr5_-_16742330 | 0.55 |
ENST00000505695.1
ENST00000427430.2 |
MYO10
|
myosin X |
chr19_-_45909585 | 0.54 |
ENST00000593226.1
ENST00000418234.2 |
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like |
chr14_+_23067146 | 0.53 |
ENST00000428304.2
|
ABHD4
|
abhydrolase domain containing 4 |
chr12_+_6881678 | 0.53 |
ENST00000441671.2
ENST00000203629.2 |
LAG3
|
lymphocyte-activation gene 3 |
chr5_+_121465234 | 0.52 |
ENST00000504912.1
ENST00000505843.1 |
ZNF474
|
zinc finger protein 474 |
chr19_+_50380917 | 0.51 |
ENST00000535102.2
|
TBC1D17
|
TBC1 domain family, member 17 |
chr18_-_2982869 | 0.51 |
ENST00000584915.1
|
LPIN2
|
lipin 2 |
chr9_-_128246769 | 0.50 |
ENST00000444226.1
|
MAPKAP1
|
mitogen-activated protein kinase associated protein 1 |
chr6_+_84563295 | 0.50 |
ENST00000369687.1
|
RIPPLY2
|
ripply transcriptional repressor 2 |
chr10_-_99094458 | 0.49 |
ENST00000371019.2
|
FRAT2
|
frequently rearranged in advanced T-cell lymphomas 2 |
chr7_-_84122033 | 0.49 |
ENST00000424555.1
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
chr12_-_86650077 | 0.49 |
ENST00000552808.2
ENST00000547225.1 |
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr6_-_27880174 | 0.46 |
ENST00000303324.2
|
OR2B2
|
olfactory receptor, family 2, subfamily B, member 2 |
chr9_-_135819987 | 0.45 |
ENST00000298552.3
ENST00000403810.1 |
TSC1
|
tuberous sclerosis 1 |
chr22_-_45404819 | 0.45 |
ENST00000447824.3
ENST00000404079.2 ENST00000420689.1 ENST00000403565.1 |
PHF21B
|
PHD finger protein 21B |
chr11_+_117049445 | 0.45 |
ENST00000324225.4
ENST00000532960.1 |
SIDT2
|
SID1 transmembrane family, member 2 |
chr16_-_57831914 | 0.45 |
ENST00000421376.2
|
KIFC3
|
kinesin family member C3 |
chr16_-_57831676 | 0.45 |
ENST00000465878.2
ENST00000539578.1 ENST00000561524.1 |
KIFC3
|
kinesin family member C3 |
chrX_-_48937531 | 0.45 |
ENST00000473974.1
ENST00000475880.1 ENST00000396681.4 ENST00000553851.1 ENST00000471338.1 ENST00000476728.1 ENST00000376368.2 ENST00000485908.1 ENST00000376372.3 ENST00000376358.3 |
WDR45
AF196779.12
|
WD repeat domain 45 WD repeat domain phosphoinositide-interacting protein 4 |
chr3_-_185826718 | 0.44 |
ENST00000413301.1
ENST00000421809.1 |
ETV5
|
ets variant 5 |
chr8_+_77593448 | 0.44 |
ENST00000521891.2
|
ZFHX4
|
zinc finger homeobox 4 |
chr5_-_142065612 | 0.44 |
ENST00000360966.5
ENST00000411960.1 |
FGF1
|
fibroblast growth factor 1 (acidic) |
chr1_+_227127981 | 0.44 |
ENST00000366778.1
ENST00000366777.3 ENST00000458507.2 |
ADCK3
|
aarF domain containing kinase 3 |
chr6_-_33168391 | 0.43 |
ENST00000374685.4
ENST00000413614.2 ENST00000374680.3 |
RXRB
|
retinoid X receptor, beta |
chr9_+_27109133 | 0.43 |
ENST00000519097.1
ENST00000380036.4 |
TEK
|
TEK tyrosine kinase, endothelial |
chr18_+_3449330 | 0.43 |
ENST00000549253.1
|
TGIF1
|
TGFB-induced factor homeobox 1 |
chr17_+_72427477 | 0.43 |
ENST00000342648.5
ENST00000481232.1 |
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr1_-_12677714 | 0.43 |
ENST00000376223.2
|
DHRS3
|
dehydrogenase/reductase (SDR family) member 3 |
chr14_+_23067166 | 0.42 |
ENST00000216327.6
ENST00000542041.1 |
ABHD4
|
abhydrolase domain containing 4 |
chr14_+_56584414 | 0.42 |
ENST00000559044.1
|
PELI2
|
pellino E3 ubiquitin protein ligase family member 2 |
chr5_+_176853702 | 0.42 |
ENST00000507633.1
ENST00000393576.3 ENST00000355958.5 ENST00000528793.1 ENST00000512684.1 |
GRK6
|
G protein-coupled receptor kinase 6 |
chr20_+_44035200 | 0.42 |
ENST00000372717.1
ENST00000360981.4 |
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
chr19_+_13906250 | 0.41 |
ENST00000254323.2
|
ZSWIM4
|
zinc finger, SWIM-type containing 4 |
chr10_+_43932282 | 0.41 |
ENST00000431662.1
ENST00000315429.6 |
ZNF487
|
zinc finger protein 487 |
chr22_-_31688381 | 0.41 |
ENST00000487265.2
|
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1 |
chr10_+_99400443 | 0.41 |
ENST00000370631.3
|
PI4K2A
|
phosphatidylinositol 4-kinase type 2 alpha |
chr7_+_30174574 | 0.41 |
ENST00000409688.1
|
C7orf41
|
maturin, neural progenitor differentiation regulator homolog (Xenopus) |
chr17_+_41561317 | 0.41 |
ENST00000540306.1
ENST00000262415.3 ENST00000605777.1 |
DHX8
|
DEAH (Asp-Glu-Ala-His) box polypeptide 8 |
chr9_+_140125385 | 0.41 |
ENST00000361134.2
|
SLC34A3
|
solute carrier family 34 (type II sodium/phosphate contransporter), member 3 |
chr19_+_41725140 | 0.40 |
ENST00000359092.3
|
AXL
|
AXL receptor tyrosine kinase |
chr7_+_114055052 | 0.39 |
ENST00000462331.1
ENST00000408937.3 ENST00000403559.4 ENST00000350908.4 ENST00000393498.2 ENST00000393495.3 ENST00000378237.3 ENST00000393489.3 |
FOXP2
|
forkhead box P2 |
chr8_+_77593474 | 0.39 |
ENST00000455469.2
ENST00000050961.6 |
ZFHX4
|
zinc finger homeobox 4 |
chr1_+_65730385 | 0.39 |
ENST00000263441.7
ENST00000395325.3 |
DNAJC6
|
DnaJ (Hsp40) homolog, subfamily C, member 6 |
chr14_-_54418598 | 0.39 |
ENST00000609748.1
ENST00000558961.1 |
BMP4
|
bone morphogenetic protein 4 |
chr8_+_99956759 | 0.38 |
ENST00000522510.1
ENST00000457907.2 |
OSR2
|
odd-skipped related transciption factor 2 |
chr1_+_33722080 | 0.38 |
ENST00000483388.1
ENST00000539719.1 |
ZNF362
|
zinc finger protein 362 |
chr1_-_207095324 | 0.38 |
ENST00000530505.1
ENST00000367091.3 ENST00000442471.2 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr17_+_26662597 | 0.38 |
ENST00000544907.2
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
chr7_-_105332084 | 0.38 |
ENST00000472195.1
|
ATXN7L1
|
ataxin 7-like 1 |
chr1_-_161337662 | 0.38 |
ENST00000367974.1
|
C1orf192
|
chromosome 1 open reading frame 192 |
chr5_+_176853669 | 0.38 |
ENST00000355472.5
|
GRK6
|
G protein-coupled receptor kinase 6 |
chr19_+_50380682 | 0.38 |
ENST00000221543.5
|
TBC1D17
|
TBC1 domain family, member 17 |
chr19_-_6057282 | 0.38 |
ENST00000592281.1
|
RFX2
|
regulatory factor X, 2 (influences HLA class II expression) |
chr16_-_84150492 | 0.38 |
ENST00000343411.3
|
MBTPS1
|
membrane-bound transcription factor peptidase, site 1 |
chr16_-_57832004 | 0.37 |
ENST00000562503.1
|
KIFC3
|
kinesin family member C3 |
chr15_+_80733570 | 0.36 |
ENST00000533983.1
ENST00000527771.1 ENST00000525103.1 |
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2 |
chr11_+_33061543 | 0.36 |
ENST00000432887.1
ENST00000528898.1 ENST00000531632.2 |
TCP11L1
|
t-complex 11, testis-specific-like 1 |
chr3_-_48956818 | 0.36 |
ENST00000408959.2
|
ARIH2OS
|
ariadne homolog 2 opposite strand |
chr2_-_27434611 | 0.36 |
ENST00000408041.1
|
SLC5A6
|
solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 |
chr3_+_9691117 | 0.36 |
ENST00000353332.5
ENST00000420925.1 ENST00000296003.4 ENST00000351233.5 |
MTMR14
|
myotubularin related protein 14 |
chr8_+_99956662 | 0.36 |
ENST00000523368.1
ENST00000297565.4 ENST00000435298.2 |
OSR2
|
odd-skipped related transciption factor 2 |
chr1_-_168106536 | 0.36 |
ENST00000537209.1
ENST00000361697.2 ENST00000546300.1 ENST00000367835.1 |
GPR161
|
G protein-coupled receptor 161 |
chr7_-_5463175 | 0.35 |
ENST00000399537.4
ENST00000430969.1 |
TNRC18
|
trinucleotide repeat containing 18 |
chr1_-_153931052 | 0.35 |
ENST00000368630.3
ENST00000368633.1 |
CRTC2
|
CREB regulated transcription coactivator 2 |
chr17_+_59477233 | 0.35 |
ENST00000240328.3
|
TBX2
|
T-box 2 |
chr17_+_73455788 | 0.34 |
ENST00000581519.1
|
KIAA0195
|
KIAA0195 |
chr20_+_56964169 | 0.34 |
ENST00000475243.1
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C |
chr17_-_42580738 | 0.34 |
ENST00000585614.1
ENST00000591680.1 ENST00000434000.1 ENST00000588554.1 ENST00000592154.1 |
GPATCH8
|
G patch domain containing 8 |
chr6_-_42016385 | 0.33 |
ENST00000502771.1
ENST00000508143.1 ENST00000514588.1 ENST00000510503.1 ENST00000415497.2 ENST00000372988.4 |
CCND3
|
cyclin D3 |
chr11_+_844406 | 0.33 |
ENST00000397404.1
|
TSPAN4
|
tetraspanin 4 |
chr1_-_94079648 | 0.33 |
ENST00000370247.3
|
BCAR3
|
breast cancer anti-estrogen resistance 3 |
chrX_-_48937503 | 0.33 |
ENST00000322995.8
|
WDR45
|
WD repeat domain 45 |
chr2_-_26205550 | 0.33 |
ENST00000405914.1
|
KIF3C
|
kinesin family member 3C |
chr11_-_72504637 | 0.33 |
ENST00000536377.1
ENST00000359373.5 |
STARD10
ARAP1
|
StAR-related lipid transfer (START) domain containing 10 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chr5_-_42812143 | 0.33 |
ENST00000514985.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
chr6_-_88875628 | 0.33 |
ENST00000551417.1
|
CNR1
|
cannabinoid receptor 1 (brain) |
chr6_-_42418999 | 0.33 |
ENST00000340840.2
ENST00000354325.2 |
TRERF1
|
transcriptional regulating factor 1 |
chr8_+_24151620 | 0.32 |
ENST00000437154.2
|
ADAM28
|
ADAM metallopeptidase domain 28 |
chr3_-_71632894 | 0.32 |
ENST00000493089.1
|
FOXP1
|
forkhead box P1 |
chr9_+_27109440 | 0.32 |
ENST00000519080.1
|
TEK
|
TEK tyrosine kinase, endothelial |
chr10_+_104535994 | 0.32 |
ENST00000369889.4
|
WBP1L
|
WW domain binding protein 1-like |
chr19_-_42916499 | 0.32 |
ENST00000601189.1
ENST00000599211.1 |
LIPE
|
lipase, hormone-sensitive |
chr2_+_111878483 | 0.32 |
ENST00000308659.8
ENST00000357757.2 ENST00000393253.2 ENST00000337565.5 ENST00000393256.3 |
BCL2L11
|
BCL2-like 11 (apoptosis facilitator) |
chr14_+_24584056 | 0.32 |
ENST00000561001.1
|
DCAF11
|
DDB1 and CUL4 associated factor 11 |
chr6_-_152623231 | 0.31 |
ENST00000540663.1
ENST00000537033.1 |
SYNE1
|
spectrin repeat containing, nuclear envelope 1 |
chr1_+_84630367 | 0.31 |
ENST00000370680.1
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr12_+_96588368 | 0.31 |
ENST00000547860.1
|
ELK3
|
ELK3, ETS-domain protein (SRF accessory protein 2) |
chr5_+_121465207 | 0.31 |
ENST00000296600.4
|
ZNF474
|
zinc finger protein 474 |
chr12_-_116714564 | 0.31 |
ENST00000548743.1
|
MED13L
|
mediator complex subunit 13-like |
chr3_+_48956249 | 0.31 |
ENST00000452882.1
ENST00000430423.1 ENST00000356401.4 ENST00000449376.1 ENST00000420814.1 ENST00000449729.1 ENST00000433170.1 |
ARIH2
|
ariadne RBR E3 ubiquitin protein ligase 2 |
chr3_-_141868293 | 0.30 |
ENST00000317104.7
ENST00000494358.1 |
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr14_-_69262916 | 0.30 |
ENST00000553375.1
|
ZFP36L1
|
ZFP36 ring finger protein-like 1 |
chr11_-_72504681 | 0.30 |
ENST00000538536.1
ENST00000543304.1 ENST00000540587.1 ENST00000334805.6 |
STARD10
|
StAR-related lipid transfer (START) domain containing 10 |
chr16_-_87729753 | 0.30 |
ENST00000538868.1
|
AC010536.1
|
Uncharacterized protein; cDNA FLJ45526 fis, clone BRTHA2027227 |
chr17_+_58755184 | 0.30 |
ENST00000589222.1
ENST00000407086.3 ENST00000390652.5 |
BCAS3
|
breast carcinoma amplified sequence 3 |
chr10_+_123923105 | 0.29 |
ENST00000368999.1
|
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
chr20_+_306221 | 0.29 |
ENST00000342665.2
|
SOX12
|
SRY (sex determining region Y)-box 12 |
chr20_+_306177 | 0.29 |
ENST00000544632.1
|
SOX12
|
SRY (sex determining region Y)-box 12 |
chr1_-_179112173 | 0.29 |
ENST00000408940.3
ENST00000504405.1 |
ABL2
|
c-abl oncogene 2, non-receptor tyrosine kinase |
chr16_+_1832902 | 0.29 |
ENST00000262302.9
ENST00000563136.1 ENST00000565987.1 ENST00000543305.1 ENST00000568287.1 ENST00000565134.1 |
NUBP2
|
nucleotide binding protein 2 |
chr15_-_83240783 | 0.29 |
ENST00000568994.1
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
chr16_+_4896659 | 0.29 |
ENST00000592120.1
|
UBN1
|
ubinuclein 1 |
chrX_+_135251835 | 0.29 |
ENST00000456445.1
|
FHL1
|
four and a half LIM domains 1 |
chrX_-_19688475 | 0.28 |
ENST00000541422.1
|
SH3KBP1
|
SH3-domain kinase binding protein 1 |
chr20_+_2082494 | 0.28 |
ENST00000246032.3
|
STK35
|
serine/threonine kinase 35 |
chr14_+_32798547 | 0.28 |
ENST00000557354.1
ENST00000557102.1 ENST00000557272.1 |
AKAP6
|
A kinase (PRKA) anchor protein 6 |
chr7_+_28448995 | 0.28 |
ENST00000424599.1
|
CREB5
|
cAMP responsive element binding protein 5 |
chr3_+_193853927 | 0.28 |
ENST00000232424.3
|
HES1
|
hes family bHLH transcription factor 1 |
chr1_+_198126209 | 0.28 |
ENST00000367383.1
|
NEK7
|
NIMA-related kinase 7 |
chr2_-_198175495 | 0.28 |
ENST00000409153.1
ENST00000409919.1 ENST00000539527.1 |
ANKRD44
|
ankyrin repeat domain 44 |
chr17_+_26662730 | 0.27 |
ENST00000226225.2
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
chr8_-_133772870 | 0.27 |
ENST00000522334.1
ENST00000519016.1 |
TMEM71
|
transmembrane protein 71 |
chr17_-_1463095 | 0.27 |
ENST00000575895.1
ENST00000573056.1 |
PITPNA
|
phosphatidylinositol transfer protein, alpha |
chr2_+_27665232 | 0.27 |
ENST00000543753.1
ENST00000288873.3 |
KRTCAP3
|
keratinocyte associated protein 3 |
chr20_-_44519839 | 0.27 |
ENST00000372518.4
|
NEURL2
|
neuralized E3 ubiquitin protein ligase 2 |
chr12_-_88423164 | 0.27 |
ENST00000298699.2
ENST00000550553.1 |
C12orf50
|
chromosome 12 open reading frame 50 |
chr1_-_8585945 | 0.27 |
ENST00000377464.1
|
RERE
|
arginine-glutamic acid dipeptide (RE) repeats |
chr5_-_150460914 | 0.27 |
ENST00000389378.2
|
TNIP1
|
TNFAIP3 interacting protein 1 |
chr5_+_133859996 | 0.27 |
ENST00000512386.1
|
PHF15
|
jade family PHD finger 2 |
chr4_-_152149033 | 0.26 |
ENST00000514152.1
|
SH3D19
|
SH3 domain containing 19 |
chr5_-_150460539 | 0.26 |
ENST00000520931.1
ENST00000520695.1 ENST00000521591.1 ENST00000518977.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
chr1_-_45956822 | 0.26 |
ENST00000372086.3
ENST00000341771.6 |
TESK2
|
testis-specific kinase 2 |
chrX_-_48937684 | 0.26 |
ENST00000465382.1
ENST00000423215.2 |
WDR45
|
WD repeat domain 45 |
chr2_+_20650796 | 0.26 |
ENST00000448241.1
|
AC023137.2
|
AC023137.2 |
chr17_+_26662679 | 0.26 |
ENST00000578158.1
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
chr2_+_27665289 | 0.26 |
ENST00000407293.1
|
KRTCAP3
|
keratinocyte associated protein 3 |
chr1_+_87797351 | 0.26 |
ENST00000370542.1
|
LMO4
|
LIM domain only 4 |
chr3_+_181429704 | 0.26 |
ENST00000431565.2
ENST00000325404.1 |
SOX2
|
SRY (sex determining region Y)-box 2 |
chr15_-_34610962 | 0.26 |
ENST00000290209.5
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
chr2_-_26205340 | 0.25 |
ENST00000264712.3
|
KIF3C
|
kinesin family member 3C |
chr10_-_105421427 | 0.25 |
ENST00000538130.1
|
SH3PXD2A
|
SH3 and PX domains 2A |
chr9_+_27109392 | 0.25 |
ENST00000406359.4
|
TEK
|
TEK tyrosine kinase, endothelial |
chr10_-_90751038 | 0.24 |
ENST00000458159.1
ENST00000415557.1 ENST00000458208.1 |
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr11_-_3663502 | 0.24 |
ENST00000359918.4
|
ART5
|
ADP-ribosyltransferase 5 |
chr6_-_131211534 | 0.24 |
ENST00000456097.2
|
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
chr20_+_48909240 | 0.24 |
ENST00000371639.3
|
RP11-290F20.1
|
RP11-290F20.1 |
chr2_-_190044480 | 0.24 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
chr1_+_229440129 | 0.24 |
ENST00000366688.3
|
SPHAR
|
S-phase response (cyclin related) |
chr4_-_40632605 | 0.24 |
ENST00000514014.1
|
RBM47
|
RNA binding motif protein 47 |
chr3_+_52245458 | 0.24 |
ENST00000459884.1
|
ALAS1
|
aminolevulinate, delta-, synthase 1 |
chr7_+_28725585 | 0.24 |
ENST00000396298.2
|
CREB5
|
cAMP responsive element binding protein 5 |
chr1_-_179112189 | 0.23 |
ENST00000512653.1
ENST00000344730.3 |
ABL2
|
c-abl oncogene 2, non-receptor tyrosine kinase |
chr3_+_187957646 | 0.23 |
ENST00000457242.1
|
LPP
|
LIM domain containing preferred translocation partner in lipoma |
chrX_-_106146547 | 0.23 |
ENST00000276173.4
ENST00000411805.1 |
RIPPLY1
|
ripply transcriptional repressor 1 |
chr16_-_4896205 | 0.23 |
ENST00000589389.1
|
GLYR1
|
glyoxylate reductase 1 homolog (Arabidopsis) |
chr8_-_124553437 | 0.23 |
ENST00000517956.1
ENST00000443022.2 |
FBXO32
|
F-box protein 32 |
chr12_-_56367101 | 0.23 |
ENST00000549233.2
|
PMEL
|
premelanosome protein |
chr7_-_84121858 | 0.23 |
ENST00000448879.1
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
chr6_+_108977520 | 0.23 |
ENST00000540898.1
|
FOXO3
|
forkhead box O3 |
chr1_+_12524965 | 0.23 |
ENST00000471923.1
|
VPS13D
|
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
chr9_+_140125209 | 0.23 |
ENST00000538474.1
|
SLC34A3
|
solute carrier family 34 (type II sodium/phosphate contransporter), member 3 |
chr2_-_27434635 | 0.23 |
ENST00000401463.1
|
SLC5A6
|
solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 |
chr19_-_39826639 | 0.22 |
ENST00000602185.1
ENST00000598034.1 ENST00000601387.1 ENST00000595636.1 ENST00000253054.8 ENST00000594700.1 ENST00000597595.1 |
GMFG
|
glia maturation factor, gamma |
chr16_+_57680840 | 0.22 |
ENST00000563862.1
ENST00000564722.1 ENST00000569158.1 |
GPR56
|
G protein-coupled receptor 56 |
chr22_-_37505449 | 0.22 |
ENST00000406725.1
|
TMPRSS6
|
transmembrane protease, serine 6 |
chr5_-_13944652 | 0.22 |
ENST00000265104.4
|
DNAH5
|
dynein, axonemal, heavy chain 5 |
chr12_+_121416340 | 0.22 |
ENST00000257555.6
ENST00000400024.2 |
HNF1A
|
HNF1 homeobox A |
chr5_-_36301984 | 0.22 |
ENST00000502994.1
ENST00000515759.1 ENST00000296604.3 |
RANBP3L
|
RAN binding protein 3-like |
chr18_+_9475668 | 0.22 |
ENST00000383432.3
|
RALBP1
|
ralA binding protein 1 |
chr7_-_83278322 | 0.22 |
ENST00000307792.3
|
SEMA3E
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
chr11_-_57089774 | 0.22 |
ENST00000527207.1
|
TNKS1BP1
|
tankyrase 1 binding protein 1, 182kDa |
chr9_+_2159850 | 0.21 |
ENST00000416751.1
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr16_-_67597789 | 0.21 |
ENST00000605277.1
|
CTD-2012K14.6
|
CTD-2012K14.6 |
chr1_+_200011711 | 0.21 |
ENST00000544748.1
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
chr1_+_40862501 | 0.21 |
ENST00000539317.1
|
SMAP2
|
small ArfGAP2 |
chrX_-_54070607 | 0.21 |
ENST00000338154.6
ENST00000338946.6 |
PHF8
|
PHD finger protein 8 |
chr19_+_12902289 | 0.21 |
ENST00000302754.4
|
JUNB
|
jun B proto-oncogene |
chr9_+_109694914 | 0.21 |
ENST00000542028.1
|
ZNF462
|
zinc finger protein 462 |
chr10_+_75668916 | 0.21 |
ENST00000481390.1
|
PLAU
|
plasminogen activator, urokinase |
chr11_+_63606373 | 0.21 |
ENST00000402010.2
ENST00000315032.8 ENST00000377809.4 ENST00000413835.2 ENST00000377810.3 |
MARK2
|
MAP/microtubule affinity-regulating kinase 2 |
chr17_+_36886478 | 0.21 |
ENST00000439660.2
|
CISD3
|
CDGSH iron sulfur domain 3 |
chrX_-_106960285 | 0.21 |
ENST00000503515.1
ENST00000372397.2 |
TSC22D3
|
TSC22 domain family, member 3 |
chr1_+_3541543 | 0.20 |
ENST00000378344.2
ENST00000344579.5 |
TPRG1L
|
tumor protein p63 regulated 1-like |
chr16_+_4421841 | 0.20 |
ENST00000304735.3
|
VASN
|
vasorin |
chr12_-_111926342 | 0.20 |
ENST00000389154.3
|
ATXN2
|
ataxin 2 |
chr1_-_179851611 | 0.20 |
ENST00000610272.1
|
RP11-533E19.7
|
RP11-533E19.7 |
chr3_+_187930429 | 0.20 |
ENST00000420410.1
|
LPP
|
LIM domain containing preferred translocation partner in lipoma |
chr2_-_233877912 | 0.20 |
ENST00000264051.3
|
NGEF
|
neuronal guanine nucleotide exchange factor |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.1 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 1.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.6 | GO:0035623 | renal glucose absorption(GO:0035623) |
0.2 | 0.7 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.2 | 0.9 | GO:1901545 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
0.2 | 1.0 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
0.1 | 1.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.6 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.1 | 1.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.4 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.1 | 0.8 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.1 | 1.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.3 | GO:1901207 | regulation of heart looping(GO:1901207) |
0.1 | 0.8 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.3 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.1 | 0.5 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.1 | 0.4 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.1 | 0.3 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.1 | 0.5 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.1 | 0.3 | GO:0045632 | negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
0.1 | 0.5 | GO:0051029 | rRNA transport(GO:0051029) |
0.1 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 1.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.5 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.1 | 0.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.6 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.4 | GO:1905072 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm development(GO:0048389) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) pattern specification involved in mesonephros development(GO:0061227) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in kidney development(GO:0072098) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
0.1 | 0.4 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.1 | 0.2 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.6 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.3 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 1.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.2 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.2 | GO:1903249 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.1 | 0.2 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.1 | 0.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 0.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.3 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.1 | 0.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.0 | 1.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.1 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.0 | 0.4 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.6 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.0 | 0.1 | GO:1902868 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.0 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.0 | 0.0 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.0 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.0 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.0 | 0.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.1 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.0 | 0.3 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.0 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.1 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.0 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.0 | 0.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.0 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 0.2 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.0 | 0.2 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.0 | 0.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.1 | GO:0043132 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) NAD transport(GO:0043132) |
0.0 | 0.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.0 | 0.2 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.0 | 0.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.5 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.1 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.0 | 1.0 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.0 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 0.2 | GO:0071486 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.0 | 0.4 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.9 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.2 | GO:2001205 | TNFSF11-mediated signaling pathway(GO:0071847) negative regulation of osteoclast development(GO:2001205) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.1 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.0 | 0.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.0 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.3 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.0 | 0.3 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.1 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.0 | 0.1 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.0 | 0.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.0 | 0.2 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
0.0 | 0.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.2 | GO:0061373 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.0 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.1 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.0 | 0.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.5 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.2 | GO:0032648 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
0.0 | 0.6 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.0 | 0.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.2 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.0 | 0.1 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 0.1 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.0 | 0.1 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.0 | 0.1 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.0 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.1 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.0 | 1.0 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.0 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.0 | 0.1 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.2 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.1 | GO:0030805 | regulation of cyclic nucleotide catabolic process(GO:0030805) negative regulation of cyclic nucleotide catabolic process(GO:0030806) regulation of cAMP catabolic process(GO:0030820) negative regulation of cAMP catabolic process(GO:0030821) regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.0 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.0 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.1 | GO:1903824 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.0 | 0.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.1 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.0 | 0.2 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.0 | 0.0 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.4 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.1 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.0 | 0.0 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.0 | 0.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 0.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.1 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.0 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.0 | 0.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.0 | 0.1 | GO:0044211 | CTP salvage(GO:0044211) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.0 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
0.0 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.1 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.0 | 0.5 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.0 | 0.1 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.1 | 0.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.2 | GO:0036457 | keratohyalin granule(GO:0036457) |
0.1 | 1.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.7 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.3 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.0 | 0.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.2 | GO:0016938 | kinesin I complex(GO:0016938) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.0 | 0.7 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 0.5 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.1 | GO:0031673 | H zone(GO:0031673) |
0.0 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 0.1 | GO:0097444 | spine apparatus(GO:0097444) |
0.0 | 0.4 | GO:0033643 | host cell part(GO:0033643) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 1.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 1.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.0 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.0 | 0.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.3 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.0 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.0 | 0.1 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 0.5 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.3 | 0.8 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.2 | 1.0 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.1 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 1.0 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.1 | 0.3 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.1 | 0.3 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.1 | 0.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.4 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.1 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.2 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.2 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.1 | 1.5 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.0 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 1.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 1.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.2 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.2 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) leukotriene receptor activity(GO:0004974) |
0.0 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.0 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
0.0 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.2 | GO:0050659 | chondroitin 4-sulfotransferase activity(GO:0047756) N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.0 | 0.1 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.0 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.0 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.0 | 0.1 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.0 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.0 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.0 | 0.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.1 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
0.0 | 0.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.0 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.0 | 1.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.1 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.0 | 0.5 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.1 | GO:0050693 | DBD domain binding(GO:0050692) LBD domain binding(GO:0050693) |
0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.1 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.0 | 0.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.0 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.0 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 0.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.1 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 0.0 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
0.0 | 0.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.0 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 1.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 2.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.6 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.8 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |